Nomura Holdings’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-72,200
Closed -$11.3M 2176
2024
Q3
$11.3M Buy
+72,200
New +$11.7M 0.03% 404
2024
Q1
Sell
-40,950
Closed -$5.52M 1628
2023
Q4
$5.52M Buy
+40,950
New +$5.32M 0.01% 630
2023
Q2
Sell
-56,275
Closed -$7.81M 1364
2023
Q1
$7.81M Buy
+56,275
New +$7.57M 0.02% 435
2022
Q4
Sell
-24,275
Closed -$2.66M 1504
2022
Q3
$2.66M Buy
+24,275
New +$3.08M 0.01% 738
2015
Q1
Sell
-733,400
Closed -$51.7M 1757
2014
Q4
$51.7M Sell
733,400
-553,100
-43% -$39.6M 0.14% 99
2014
Q3
$92M Buy
1,286,500
+626,500
+95% +$45.9M 0.25% 72
2014
Q2
$49M Buy
660,000
+410,000
+164% +$29.6M 0.01% 159
2014
Q1
$16.2M Buy
+250,000
New +$16.1M 0.01% 332

Other funds holding AZN

Nomura Holdings's AZN Position: Q2 2026 in Review

Nomura Holdings opened a new position in AstraZeneca (AZN) in Q2 2026: 95,936 shares worth $18.2M. The stake represents 0.02% of the portfolio and ranks #385 among its holdings. This is a return to the name: Nomura Holdings previously reported a position in AZN as recently as Q4 2025.

Nomura Holdings first reported a position in AZN in Q3 2013 and has held it in 22 quarters since. 1,503 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Nomura Holdings held 95,936 shares of AstraZeneca worth $18.2M as of Q2 2026.
  • AstraZeneca was a new Nomura Holdings position in Q2 2026.
  • AstraZeneca made up 0.02% of Nomura Holdings's portfolio in Q2 2026, its #385 holding.
  • Nomura Holdings first reported a position in AstraZeneca in Q3 2013 and has held it in 22 quarters since.
  • 1,503 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.